Found 4 matching trials
A Study to Compare the Bioequivalence of 50-mg Tapentadol (CG5503) Dose Administered as Two 25-mg Tablets Relative to One 50-mg Tablet PHASE1 The purpose of this study is to evaluate the bioequivalence of a 50-mg tape...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Compare the Bioequivalence of 50-mg Tapentadol (CG5503) Dose Administered as Two 50-mg Tablets Relative to One 100-mg Tablet PHASE1 The purpose of this study is to evaluate the bioequivalence of a 100-mg tap...
Show More Location
Multiple Locations
Learn More & Join Trial
A Pivotal Study to Evaluate the Bio-equivalence of the Tapentadol Extended-Release (ER) Tamper-resistant Formulation (TRF) Tablet to the Current Tapentadol ER Prolonged-release 2 (PR2) Tablet PHASE1 The purpose of this study is to evaluate bio-equivalence of tapentadol exte...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Compare the Dose-proportionality of Tapentadol (CG5503) in Healthy Japanese and Korean Male Volunteers PHASE1 The purpose of this study is to evaluate the dose-proportionality of the ph...
Show More Location
Multiple Locations
Learn More & Join Trial